Another study took place between September 2021 to late November 2022, in a total of 272 participants underwent adaptive randomization
Many patients arrive with concerns influenced by online discussions or outdated information
GLP-1 drugs have also been explored for other types of addiction, such as nicotine and opioid addiction, though results have been mixed
Expect 30-40% reduction in severity, which often makes the difference between barely functional and tolerably uncomfortable
49,55,56,67 However, most of the clinical studies conducted up to date have focused on evaluating the effects of small molecule oral GLP-1 RAs against placebo
Pricing Disclaimer All pricing information referenced in this release is approximate, current as of publication date, and subject to change at any time without notice